Enjoy complimentary customisation on priority with our Enterprise License!
Technavio's market study identifies the use of automation in data acquisition to be one of the primary factors for the growth of the automation market in biopharmaceutical industry. The implementation of automation in data acquisition makes it easier to access, analyze, and observe data from different interfaces. Additionally, it also helps in reducing the chances of error. Database collection of several processes is utilized to create a library that increases operational efficiency and process optimization. Issues and errors are detected at an earlier stage through real-time analysis and monitoring. Our industry research analysts estimate that this market will grow steadily at a CAGR of more than 6% by 2021.
Internet of Things (IoT) is an interconnection of mechanical and digital devices to transfer data without any human involvement. IoT is extensively implemented in industries and in healthcare laboratories. Wearable devices integrated with IoT have the capability to detect health problems and immediately refer life-saving drugs. Moreover, it also enables the expert to operate the processes remotely with high accuracy. This will increase the implementation of IoT in labs which will be one of the key trends that will gain traction in the automation market in biopharmaceutical industry.
The automation market in biopharmaceutical industry is concentrated due to the presence of few manufacturers, system integrators, and automation solution providers. Vendors are extensively focused on marketing their products in North America and Europe as these markets have high growth potential. Automation providers target academic research labs, clinical trial sites, FDA, research and manufacturing companies, and clinical research organizations for their product portfolio.
The leading vendors in the market are
The other prominent vendors in the market are Bruker, Peak Analysis & Automation, Waters, Capsugel, RheoSense, Eirechrom, BioProcess International, and Novasep.
Increasing R&D activities for new drug development and the increasing number of clinical trial approvals by FDA is influencing the growth of the pharma automation market. Automated equipment is used in the clinical testing and manufacturing procedures in research labs and manufacturing facilities. Vendors are increasingly focusing on making innovations to improve the scope of their products.
The Americas is the major market for new drug manufacturing for incurable diseases. The improvement in R&D facilities in therapeutic drug production and expertise in new drug formulation, in addition to the increasing aging population and prevalence of chronic diseases, will contribute to the growth of the pharma automation market in the Americas.
Technavio also offers customization on reports based on specific client requirement.
Technavio publishes a wide variety of research report from the industrial automation industry gathering information on market size, growth rate, emerging trends, and key growth drivers. The upcoming report on global automation market in biopharmaceutical industry also identifies some of the vendors competing in this market and affecting the automation sector as ThermoFisher and Rockwell Automation.
Research analysts at Technavio go through a rigorous analysis of research journals, expert opinions, telephone surveys and interviews, and client survey to oversee primary and secondary research. The information thus collected helps the client achieve their business objectives by serving as an essential business input tool which accurately forecasts the growth potential of the market.
The report on the global automation market in biopharmaceutical industry also analyses geographic regions such as Americas, APAC, and EMEA by their relative market size, market share, and emerging trends in each region. Due to increasing demand for pharmaceuticals across the globe, the automation market in biopharmaceutical industry might be on the rise.
The upcoming research report on global automation market in biopharmaceutical industry also includes market intelligence parameters such as technological advancements, profits, manufacturing, competition, technology, competitive landscape, business users and opportunities and challenges faced by the industry. The report also covers related sectors from industrial automation such as robotics sector.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by application
PART 07: Geographical segmentation
PART 08: Decision framework
PART 09: Drivers and challenges
PART 10: Market trends
PART 11: Vendor landscape
PART 12: Key vendor analysis
PART 13: Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.